Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 44

1.

Trans-nonachlor decreases miR-141-3p levels in human melanocytes in vitro promoting melanoma cell characteristics and shows a multigenerational impact on miR-8 levels in Drosophila.

Verrando P, Capovilla M, Rahmani R.

Toxicology. 2016 Aug 10;368-369:129-141. doi: 10.1016/j.tox.2016.09.003. Epub 2016 Sep 9.

PMID:
27616325
2.

Resistance to cisplatin-induced cell death conferred by the activity of organic anion transporting polypeptides (OATP) in human melanoma cells.

Silvy F, Lissitzky JC, Bruneau N, Zucchini N, Landrier JF, Lombardo D, Verrando P.

Pigment Cell Melanoma Res. 2013 Jul;26(4):592-6. doi: 10.1111/pcmr.12108. Epub 2013 May 3.

PMID:
23582189
3.

Gene expression profiles of human melanoma cells with different invasive potential reveal TSPAN8 as a novel mediator of invasion.

Berthier-Vergnes O, El Kharbili M, de la Fouchardière A, Pointecouteau T, Verrando P, Wierinckx A, Lachuer J, Le Naour F, Lamartine J.

Br J Cancer. 2011 Jan 4;104(1):155-65. doi: 10.1038/sj.bjc.6605994. Epub 2010 Nov 16.

4.

Cyclic AMP signaling as a mediator of vasculogenic mimicry in aggressive human melanoma cells in vitro.

Lissitzky JC, Parriaux D, Ristorcelli E, Vérine A, Lombardo D, Verrando P.

Cancer Res. 2009 Feb 1;69(3):802-9. doi: 10.1158/0008-5472.CAN-08-2391. Epub 2009 Jan 27.

5.

Human tumor nanoparticles induce apoptosis of pancreatic cancer cells.

Ristorcelli E, Beraud E, Verrando P, Villard C, Lafitte D, Sbarra V, Lombardo D, Verine A.

FASEB J. 2008 Sep;22(9):3358-69. doi: 10.1096/fj.07-102855. Epub 2008 May 29.

PMID:
18511551
6.

Killing efficacy of a new silicon phthalocyanine in human melanoma cells treated with photodynamic therapy by early activation of mitochondrion-mediated apoptosis.

Barge J, Decréau R, Julliard M, Hubaud JC, Sabatier AS, Grob JJ, Verrando P.

Exp Dermatol. 2004 Jan;13(1):33-44.

PMID:
15009114
8.

Evaluation of sunscreen protection in human melanocytes exposed to UVA or UVB irradiation using the alkaline comet assay.

Jean S, De Méo M, Sabatier AS, Laget M, Hubaud JC, Verrando P, Duménil G.

Photochem Photobiol. 2001 Sep;74(3):417-23.

PMID:
11594055
9.

Pancreatitis associated protein I (PAP-I) alters adhesion and motility of human melanocytes and melanoma cells.

Valery C, Vasseur S, Sabatier F, Iovanna JL, Dagorn JC, Grob JJ, Verrando P.

J Invest Dermatol. 2001 Mar;116(3):426-33.

10.

Tumor necrosis factor alpha triggers antiapoptotic mechanisms in rat pancreatic cells through pancreatitis-associated protein I activation.

Malka D, Vasseur S, Bödeker H, Ortiz EM, Dusetti NJ, Verrando P, Dagorn JC, Iovanna JL.

Gastroenterology. 2000 Sep;119(3):816-28.

PMID:
10982776
11.

Photodynamic activities of silicon phthalocyanines against achromic M6 melanoma cells and healthy human melanocytes and keratinocytes.

Decreau R, Richard MJ, Verrando P, Chanon M, Julliard M.

J Photochem Photobiol B. 1999 Jan;48(1):48-56.

PMID:
10205878
12.

Insulin stimulates haptotactic migration of human epidermal keratinocytes through activation of NF-kappa B transcription factor.

Benoliel AM, Kahn-Perles B, Imbert J, Verrando P.

J Cell Sci. 1997 Sep;110 ( Pt 17):2089-97.

13.

Adhesive and migratory behaviors of nevus cells differ from those of epidermal melanocytes and are not linked to the histological type of nevus.

Mengeaud V, Grob JJ, Bongrand P, Richard MA, Hesse S, Bonerandi JJ, Verrando P.

J Invest Dermatol. 1996 Jun;106(6):1224-9.

14.

Keratinocytes from junctional epidermolysis bullosa do adhere and migrate on the basement membrane protein nicein through alpha 3 beta 1 integrin.

Verrando P, Lissitzky JC, Sarret Y, Winberg JO, Gedde-Dahl T Jr, Schmitt D, Bruckner-Tuderman L.

Lab Invest. 1994 Oct;71(4):567-74.

PMID:
7967512
15.

The 100-kDa chain of nicein/kalinin is a laminin B2 chain variant.

Vailly J, Verrando P, Champliaud MF, Gerecke D, Wagman DW, Baudoin C, Aberdam D, Burgeson R, Bauer E, Ortonne JP.

Eur J Biochem. 1994 Jan 15;219(1-2):209-18.

16.

[Dermo-epidermal junction: current update].

Sarret Y, Nicolas JF, Verrando P, Schmitt D.

Ann Dermatol Venereol. 1994;121(5):419-28. Review. French. No abstract available.

PMID:
7702272
17.

Nicein (BM-600) in junctional epidermolysis bullosa: polyclonal antibodies provide new clues for pathogenic role.

Verrando P, Schofield O, Ishida-Yamamoto A, Aberdam D, Partouche O, Eady RA, Ortonne JP.

J Invest Dermatol. 1993 Nov;101(5):738-43.

18.

Basement membrane proteins kalinin and nicein are structurally and immunologically identical.

Marinkovich MP, Verrando P, Keene DR, Meneguzzi G, Lunstrum GP, Ortonne JP, Burgeson RE.

Lab Invest. 1993 Sep;69(3):295-9.

PMID:
8377472
19.

The basement membrane protein BM-600/nicein codistributes with kalinin and the integrin alpha 6 beta 4 in human cultured keratinocytes.

Marchisio PC, Cremona O, Savoia P, Pellegrini G, Ortonne JP, Verrando P, Burgeson RE, Cancedda R, De Luca M.

Exp Cell Res. 1993 Apr;205(2):205-12.

PMID:
8482332
20.

Labeling of fractured human skin with antibodies to BM 600/nicein, epiligrin, kalinin and other matrix components.

Ceilley E, Watanabe N, Shapiro D, Verrando P, Bauer EA, Burgeson R, Briggaman RA, Woodley DT.

J Dermatol Sci. 1993 Apr;5(2):97-103.

PMID:
8357788

Supplemental Content

Loading ...
Support Center